Ranibizumab is used for diabetic eye disease, wet age-related macular degeneration, and macular edema due to retinal vein occlusion.
How Ranibizumab works Ranibizumab is a monoclonal antibody that functions in cancer treatment by inhibiting the formation of blood vessels that supply oxygen and nutrients to cancerous cells. This action may slow the growth and spread of cancer.
Common side effects of Ranibizumab include conjunctival hemorrhage, eye pain, increased intraocular pressure, foreign body sensation in the eyes, blurred vision, nausea, dry eye, eye itching, cataract, vitreous floaters, vitreous detachment, intraocular inflammation, eye irritation, increased lacrimation, eyelid inflammation, ocular hyperemia, retinal disorder, maculopathy, eye discomfort, posterior capsule opacification, injection site hemorrhage, nasopharyngitis (inflammation of the throat and nasal passages), anemia (low number of red blood cells), joint pain, renal failure, peripheral neuropathy (tingling and numbness in the feet and hands), gastroesophageal reflux disease, hypercholesterolemia (high cholesterol), and bronchitis (inflammation of the airways).
Ranibizumab 2.3mg

₹17,000
Ranibizumab 10mg

₹271
Ranibizumab 2.3mg

₹19,800
Ranibizumab 10mg

₹18,000
Ranibizumab 0.5mg

₹70,160
Ranibizumab 0.5mg

₹70,160
Ranibizumab 10mg

₹23,960
Ranibizumab 0.5mg

₹15,000
Ranibizumab 0.5mg

₹19,990